🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Multiple sclerosis (MS) is at onset an immune-mediated demyelinating diseas...
Status
Completed
Location
Northwestern University, Feinberg School of Medicine
Start Date
2005-11-16
Trial ID
NCT00273364
Treatments Being Tested
In this study, we aimed to evaluate the long term efficacy, remission, surv...
Status
Completed
Location
National Clinical Research Center of Kidney Diseases, Jinling Hospital
Start Date
2011-06-01
Trial ID
NCT03828071
Treatments Being Tested
Over recent decades, improvements have been made in the treatment of adult ...
Status
Completed
Location
Hospices Civils de Lyon - Centre Hospitalier Lyon Sud, 165 Chemin du Grand Revoyet
Start Date
2013-01
Trial ID
NCT02842112
Treatments Being Tested
This phase II trial is studying how well giving rituximab together with com...
Status
Completed
Location
Eastern Cooperative Oncology Group
Start Date
2007-05
Trial ID
NCT00433537
To assess the efficacy and toxicity of plerixafor (AMD 3100) together with ...
Status
Completed
Location
Dept of Haematology, University of Liverpool
Start Date
2010-05
Trial ID
NCT01186224
Treatments Being Tested
Unfortunately, some patients with Crohn's disease (CD) fail to respond to t...
Status
Recruiting
Location
Cedars-Sinai Medical Center
Start Date
2019-11-15
Trial ID
NCT04224558
The aim of this study is to determine whether alternating courses of cyclop...
Status
Unknown
Location
Groupe D´Etudes des Lymphomes De l´Adulte (GELA)
Start Date
2004-07
Trial ID
NCT00209222
Treatments Being Tested
Neuromyelitis Optica (NMO) is a demyelinating and degenerative disorder of ...
Status
Terminated
Location
Foothills Medical Centre, University of Calgary
Start Date
2011-03
Trial ID
NCT01339455
Treatments Being Tested
Primary study objective is the evaluation of efficacy of autologous hematop...
Status
Completed
Location
Wonkwang University Hospital
Start Date
2010-01-11
Trial ID
NCT01050036
Treatments Being Tested
The current standard of care for the frontline treatment of peripheral T-ce...
Status
Terminated
Location
Brigham and Women's Hospital
Start Date
2013-07
Trial ID
NCT01746173